Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

InfraReDx Inc.

Jan 2007
InfraReDx Inc. of Burlington, Mass., has received 501(k) clearance from the FDA to market its near-infrared spectroscopic system for coronary artery examination. The corporation hopes that the catheter-based, fiber optic device, which has a laser light source, will enable cardiologists to characterize plaque composition and identify potentially rupture-prone lipid-based plaques. Recently, the company closed a $22.3 million round of funding to complete studies and finalize product development in preparation for a 2007 launch of the device.

BiophotonicsFDAInfraReDx Inc.near-infrared spectroscopic systemNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!